Kidney Transplant for International Patients in India

Kidney transplantation can provide better survival, quality of life and freedom from dialysis for many suitable patients with irreversible kidney failure. Successful transplantation, however, depends on much more than the operation: the recipient must be medically suitable, the donor must be independently and ethically evaluated, compatibility must be assessed, legal authorization completed and lifelong immunosuppression and follow-up assured.

For international patients, living-donor transplantation is usually the practical pathway in India because deceased-donor allocation follows regulated state/national systems and is not a simple on-demand option for overseas visitors. Donor relationship, nationality, documentation and authorization requirements must be clarified with the transplant hospital before travel. Commercial organ purchase is illegal and medically unethical.

A transplant opinion should therefore address recipient fitness, donor safety, blood group, HLA testing, crossmatch, donor-specific antibodies, infection screening, cardiac risk, cause of kidney failure and the ability to continue immunosuppressive medicines and laboratory monitoring after returning home. Kidney failure, dialysis and the search for a donor are exhausting for patients and families. This guide is written to help you understand the questions that matter, ask for an honest assessment of suitability and recognize a lawful, ethical programme. It does not promise outcomes; every illness and every patient is different.

Why Do International Patients Choose India for Kidney Transplant?

Patients travel for kidney transplant for practical reasons, and the strongest ones are about reaching an experienced living-donor programme at a price that does not force a compromise on safety:

• Lower cost. Private Indian hospitals often quote much less than self-pay prices in the USA, UK, Australia and other high-cost markets, although complications can narrow the gap if they are not budgeted for.
• Established living-donor programmes. Major centres perform large numbers of living-donor kidney transplants, with laparoscopic donor surgery.
• Immunology expertise. Advanced HLA laboratories and, at selected centres, ABO-incompatible and paired-exchange expertise.
• Comprehensive backup. Transplant nephrology, surgery, dialysis, ICU, infectious disease, and interventional radiology and urology are often in the same hospital.
• Multidisciplinary review. A transplant committee can judge suitability and the safest pathway before any date is set.
• Timely access. Patients facing long waits or no local living-donor option can often be assessed promptly once the records are reviewed, though a rushed decision helps no one.
• International patient support and English-speaking teams. Major hospitals typically help with appointments, hospital letters for visas, airport pick-up and accommodation guidance.
• A plan you can review first. A remote review can state whether transplant looks appropriate before you commit to travel, and may show that it is not suitable or not yet needed.

How Does India Compare with Other Medical Travel Destinations?

Many patients also look at transplant programmes abroad before deciding. There is no single best country for every patient; the right choice depends on where you live, your illness and what you can verify about the team and hospital. These are the factors worth comparing:

Who May Need a Kidney Transplant for International Patients in India

Transplantation is considered for irreversible advanced kidney failure when expected benefit outweighs surgical and immunosuppressive risk. Evaluation can begin before dialysis in suitable patients. Pre-emptive transplantation can avoid time on dialysis when a suitable donor and timely approval are available.

When Transplant May Not Be Appropriate Yet

Uncontrolled infection, active untreated cancer, severe uncorrectable cardiovascular disease, active substance misuse or inability to adhere to lifelong therapy can make transplantation unsafe. Some contraindications are temporary and can be corrected. Age alone is not an absolute exclusion.

Finding the Cause of Kidney Failure

Diabetes, hypertension, glomerular diseases, polycystic kidney disease, congenital disorders and other causes can lead to kidney failure. The original diagnosis matters because some diseases can recur in the transplanted kidney. Prior biopsy reports should be shared.

Recipient Medical Evaluation

Assessment commonly includes cardiovascular testing, infection screening, cancer screening appropriate to age/risk, vascular anatomy, bladder/urological assessment when indicated, dental/infection review and psychosocial/adherence evaluation. Dialysis adequacy and nutritional status are also important.

Cardiac Evaluation

Cardiovascular disease is a major cause of complications in kidney-failure patients. ECG, echocardiography and selective ischemia/coronary testing are used according to symptoms and risk. Unnecessary invasive testing should be avoided, but major untreated disease can change transplant timing.

Infection Screening

Screening commonly addresses hepatitis B/C, HIV, tuberculosis risk, CMV/EBV and other infections according to region and protocol. Active infection should be treated before transplantation. Latent infections may require prophylaxis.

Cancer Screening

Immunosuppression can accelerate certain cancers, so age-appropriate screening and evaluation of prior malignancy are important. Waiting periods after cancer treatment depend on cancer type, stage and recurrence risk. Decisions are individualized.

Recipient Evaluation - At a Glance

Living Kidney Donor for International Patients in India

A living donor must be medically and psychologically suitable, fully informed and acting voluntarily. Evaluation protects the donor independently of the recipient's need. Not every willing relative is medically acceptable.

Donor Kidney Function

Serum creatinine/eGFR, urine testing and sometimes measured GFR assess donor renal reserve. Significant kidney disease, proteinuria or other risk factors may exclude donation. Long-term donor risk is estimated rather than assumed to be zero.

Donor CT Angiography

CT angiography maps renal arteries, veins and anatomy for nephrectomy planning and can identify stones or structural abnormalities. Multiple vessels do not always preclude donation but can increase technical complexity.

Donor Blood Pressure and Metabolic Risk

Hypertension, obesity, diabetes risk and cardiovascular profile require careful evaluation because donation reduces renal reserve. Young donors with high lifetime metabolic risk deserve particular caution.

Living-Donor Evaluation - At a Glance

Blood-Group Compatibility

ABO-compatible transplantation is simplest immunologically. Some blood-group combinations are naturally compatible while others require desensitization or paired exchange. Blood group alone does not determine overall compatibility.

HLA Typing

HLA testing describes donor-recipient tissue antigens. Better matching can reduce immunologic risk, but modern living-donor transplantation can succeed with substantial HLA mismatch when crossmatch/antibody assessment is acceptable. HLA-identical sibling donors are uncommon but favourable.

Crossmatch

Crossmatch tests whether recipient antibodies react against donor lymphocytes. A positive crossmatch can indicate high risk of immediate/antibody-mediated rejection. Assay type and antibody strength matter.

Donor-Specific Antibodies

DSA testing identifies recipient antibodies directed against donor HLA. Presence, strength and complement-binding characteristics can influence suitability and desensitization. Interpretation should be performed by an experienced transplant immunology laboratory.

Sensitized Recipient

Prior transplant, pregnancy and blood transfusions can generate HLA antibodies and make donor matching more difficult. Highly sensitized patients may need paired exchange, alternative donors or specialized desensitization. Unnecessary transfusions should be avoided where possible.

ABO-Incompatible Kidney Transplant for International Patients in India

Selected blood-group-incompatible living-donor transplants can be performed after reducing anti-A/B antibodies using therapies such as plasmapheresis/immunoadsorption and B-cell-directed treatment according to protocol. Cost and infection risk can be higher than compatible transplantation.

Paired Kidney Exchange

When a willing donor is incompatible with the intended recipient, two or more donor-recipient pairs can exchange donors to create compatible transplants. Legal/logistical rules apply. This can avoid intensive desensitization in some cases.

Compatibility Tests - At a Glance

Deceased-Donor Kidney Transplant

Deceased-donor kidneys are allocated through regulated waiting-list systems using medical and policy criteria. Eligibility and access for foreign nationals are jurisdiction-specific and should never be assumed. International patients should verify current official policy through the transplant centre.

Legal and Ethical Authorization

India regulates organ transplantation. Hospitals must verify donor identity, relationship/affection where applicable, voluntariness and absence of commercial dealing; authorization committee review may be required. Foreign documents may need embassy/consular or other formal verification depending on the case.

Commercial Organ Purchase Is Illegal

Payment for a kidney or organ brokerage is prohibited. Patients should avoid anyone promising a purchased donor, guaranteed unrelated donor or bypass of authorization procedures. Use only licensed transplant programmes.

Pre-Emptive Kidney Transplant

A suitable transplant performed before dialysis can avoid dialysis access and some dialysis-related complications. It requires timely donor evaluation and recipient readiness. Transplant should not be rushed if donor safety or diagnosis is uncertain.

Dialysis Before Transplant

Hemodialysis or peritoneal dialysis maintains patients while awaiting transplantation. Adequate dialysis, fluid control and infection management improve operative readiness. A functioning dialysis plan is necessary until the new kidney works reliably.

Transplant Operation

The donor kidney is usually placed in the lower abdomen. Renal artery and vein are connected to iliac vessels and the ureter is implanted into the bladder. Native kidneys usually remain unless there is a specific indication for removal. The operation commonly lasts several hours.

Laparoscopic Donor Nephrectomy

Most living donors can undergo minimally invasive nephrectomy, reducing incision size and accelerating early recovery compared with traditional open surgery. Donor safety and vascular control remain paramount.

Robotic Donor/Recipient Surgery

Robotic techniques are available at selected centres for donor nephrectomy or recipient transplantation. They may offer selected technical advantages but are not necessary for excellent outcomes. Programme experience matters more than technology branding.

Immediate Graft Function

Many living-donor kidneys begin producing urine promptly, but urine output alone does not define complete graft function. Creatinine trend and clinical status are monitored closely. Fluid replacement is carefully managed.

Delayed Graft Function

Some kidneys take days to recover and temporary dialysis may be required. DGF is more common after deceased-donor transplantation but can occur in living-donor cases. It does not automatically mean graft failure.

Induction Immunosuppression

Antibody therapy may be given around transplantation to reduce early rejection risk. Choice depends on immunologic risk, infection risk and centre protocol. Higher-risk induction can increase infection susceptibility.

Maintenance Immunosuppression

Common regimens combine a calcineurin inhibitor, antimetabolite and corticosteroid, with individualized modifications. Drug levels and kidney function require regular monitoring. Missing doses can precipitate rejection.

Tacrolimus Monitoring

Tacrolimus has a narrow therapeutic range and interacts with many medicines/foods. Trough levels are checked frequently early after transplant and less often once stable. Both excessive and inadequate exposure can harm the graft.

Acute Rejection

Rejection can be T-cell-mediated or antibody-mediated and may present with rising creatinine without obvious symptoms. Biopsy often defines the mechanism. Many acute rejection episodes are treatable when recognized promptly.

Kidney Transplant Biopsy for International Patients in India

Biopsy is used to investigate unexplained graft dysfunction, proteinuria or suspected rejection. Pathology distinguishes rejection from drug toxicity, recurrent disease and other causes. Treatment should ideally be mechanism-specific.

Antibody-Mediated Rejection

ABMR involves donor-specific antibodies and microvascular injury. Treatment may include combinations of plasmapheresis, immunoglobulin and other immunomodulatory therapies depending on timing/severity. Chronic antibody injury can threaten long-term graft survival.

Possible Problems and What to Ask

Vascular Complications

Renal artery/vein thrombosis, stenosis and bleeding are uncommon but important. Doppler ultrasound is frequently used when graft perfusion is questioned. Early thrombosis can require emergency intervention.

Urological Complications

Urine leak, ureteric obstruction/stricture and lymphocele can occur. Ureteric stents are commonly used temporarily and removed later. Many complications can be treated endoscopically or radiologically.

Infection After Transplant

Immunosuppression increases bacterial, viral and fungal infection risk. The pattern changes over time after transplant and according to prophylaxis/exposure. Fever should be assessed promptly rather than treated empirically at home.

CMV and BK Virus

CMV can cause systemic illness and organ disease; BK polyomavirus can injure the transplanted kidney. Surveillance/prophylaxis strategies vary by donor-recipient risk and centre. Reducing immunosuppression may be important for BK infection.

Post-Transplant Diabetes

Steroids and calcineurin inhibitors can worsen glucose metabolism. Diabetes after transplant increases cardiovascular and infection risk. Glucose should be monitored and treated early.

Blood Pressure and Cardiovascular Risk

Hypertension remains common after transplantation. Blood pressure, lipids, diabetes, smoking and weight require long-term management. A functioning graft does not eliminate cardiovascular risk.

Recurrence of Original Kidney Disease for International Patients in India

Some glomerular diseases can recur in the transplanted kidney, including FSGS, IgA nephropathy and membranous disease. Recurrence risk varies substantially by diagnosis. Accurate native-kidney diagnosis improves counselling.

Recurrent FSGS

Primary FSGS can recur rapidly after transplantation and cause heavy proteinuria. Prior graft recurrence and disease characteristics influence risk. High-risk patients need an explicit surveillance/treatment plan.

Polycystic Kidney Disease

Native polycystic kidneys usually remain after transplantation unless size, infection, bleeding, pain or malignancy risk creates a reason for nephrectomy. Timing can be before, during or after transplant depending on anatomy.

Transplant in Diabetic Kidney Disease

Diabetes is a common cause of kidney failure. Cardiovascular and vascular assessment is especially important, and diabetes management continues after transplantation. Selected type 1 diabetic patients may be evaluated for pancreas-kidney strategies where available.

Vaccination

Vaccines should be updated before transplantation when possible because immune responses are stronger before immunosuppression. Live vaccines are generally avoided after transplant. A written vaccination plan should be provided.

Food and Infection Precautions

Early after transplant, safe food/water handling, hand hygiene and avoidance of high-risk infectious exposures are sensible. Excessive isolation is unnecessary once stable. Grapefruit and some herbal products can interact with immunosuppressants.

Donor Recovery

Living donors commonly mobilize early and leave hospital within several days after uncomplicated laparoscopic nephrectomy. Return to normal activity occurs progressively over several weeks. Long-term follow-up of blood pressure and kidney function is recommended.

Long-Term Donor Health

Most carefully selected donors maintain good long-term health, but donation is not risk-free. Remaining kidney function compensates, while lifetime kidney-failure risk is slightly higher than in comparable healthy non-donors in absolute terms still generally low. Pregnancy and metabolic risk require individualized counselling.

Pregnancy After Kidney Transplant for International Patients in India

Pregnancy can be successful after stable transplantation, but timing, graft function, blood pressure and medication safety must be reviewed. Some immunosuppressants are teratogenic and must be changed well before conception. High-risk obstetric and transplant follow-up is required.

Pregnancy After Kidney Donation

Many donors can have successful pregnancies, though hypertensive pregnancy disorders may be somewhat more frequent after donation. Women should discuss timing and risk with the donor team. Donation decisions should include reproductive plans.

Graft Survival

Living-donor kidneys generally have excellent outcomes, but survival varies with donor/recipient age, immunologic risk, disease recurrence, adherence, infections and cardiovascular health. No centre can guarantee lifetime graft function.

Preparing Yourself Before Kidney Transplant (Prehab)

Preparation helps recovery. Always agree what is appropriate with your transplant team, and never let preparation delay urgent treatment:

• Keeping dialysis adequate and attending every session, with fluid and potassium limits as advised
• Dietitian review of protein, salt, potassium and phosphate, and a plan for food safety after transplant
• Gentle, regular activity such as daily walking, as advised by your team
• Stopping smoking and limiting alcohol
• Treating infections, anemia and other problems that could raise risk, and keeping vaccinations up to date as advised
• A medicine review, including supplements and herbal products, which can harm kidneys or interfere with immunosuppressants
• Learning the warning signs and the importance of never missing an immunosuppressant dose
• For the donor, a separate, independent medical and psychosocial evaluation, healthy weight and blood pressure, and avoiding nephrotoxic drugs
• Practical and emotional support arranged for recipient, donor and caregiver

Preparation should never delay urgent treatment. Your team will tell you if time is critical.

Around Kidney Transplant: What to Expect

Choosing a Kidney Transplant Surgeon in India

Look for a transplant surgeon and nephrologist working within an established programme with transparent recipient/donor outcomes, strong immunology, interventional radiology and critical-care support. Ask about programme volume, graft/patient survival and complication management.

Choosing a Transplant Centre

A comprehensive centre needs transplant nephrology, surgery, HLA/immunology laboratory, infectious-disease support, dialysis, ICU, interventional radiology/urology and a structured donor-safety programme. For international patients, legal coordination and post-return communication are essential.

Major Kidney Transplant Hubs in India

Delhi NCR, Mumbai, Chennai, Bengaluru, Hyderabad, Kolkata and other tertiary centres have established living-donor kidney-transplant programmes. ABO-incompatible and paired-exchange expertise varies by centre. Choose according to immunologic complexity and programme outcomes rather than city alone.

Warning Signs of an Unreliable or Unethical Offer

Medical travel works best when the information you receive is specific, itemized, lawful and clinically sensible. Be cautious if you see any of the following:

What a Good International Patient Service Should Provide

A well-run programme should make the journey easier and safer at every stage:

• A named coordinator and a direct line to the clinical team before you travel
• Review of your actual records and the donor's information by the transplant team, and a written preliminary opinion that distinguishes preliminary suitability from final approval
• Clear explanation of the legal pathway, required documents and the independent donor assessment and authorization process for your nationality and relationship
• Honest discussion of alternatives, including treatment closer to home, dialysis and whether travel is necessary at all
• An itemized written estimate with separate recipient and donor costs, and clear exclusions for dialysis, plasmapheresis, rejection therapy, infection and readmission
• A hospital letter for your medical visa application, and guidance for attendant and donor visas
• Airport pick-up, assistance on arrival and accommodation near the hospital for weeks
• Interpreter support where needed
• Operative reports, immunology results, creatinine trend, discharge medicines, prophylaxis plan and a monitoring schedule for the recipient, and a follow-up plan for the donor
• A defined shared-care pathway after you return home, including teleconsultations with the transplant team

Indicative Kidney Transplant Costs for International Patients in India

These are broad private international-patient planning estimates, not guaranteed tariffs. ICU care, plasmapheresis, immunoglobulin, rejection, infection, dialysis, reoperation, prolonged admission and high-cost immunologic therapy can substantially increase final cost.

What a Kidney Transplant Package Should Include

Request separate recipient and donor evaluation details, HLA/crossmatch/DSA testing, authorization coordination, donor nephrectomy, recipient transplant surgery, anesthesia, ICU/ward assumptions, induction medicines, routine laboratory/drug-level monitoring, ureteric stent removal and early outpatient follow-up. Clarify dialysis, plasmapheresis, blood products, rejection therapy, infection treatment and readmission exclusions.

Factors That Increase Total Cost

ABO incompatibility, high DSA/sensitization, repeated plasmapheresis, delayed graft function requiring dialysis, rejection, severe infection, vascular/urological intervention, ICU stay and prolonged accommodation can materially increase total expenditure.

Kidney Transplant Cost - India vs USA, UK and Australia

*Broad private/self-pay comparisons only. Public transplant programmes and deceased-donor allocation systems abroad are not directly comparable. Costs should never be used to justify illegal organ procurement.

Budgeting for the Whole Pathway, Not Just the Operation

The operation is only one part of the budget. Ask for the transplant quotation, then add:

• A contingency for rejection, plasmapheresis, dialysis, delayed graft function, infection or readmission, which can materially raise the final bill
• Separate recipient and donor evaluation costs, and donor hospital days
• Post-transplant medicines, drug-level tests and monitoring (broadly US$300-1,000+ per month in the first months), and lifelong immunosuppression at home
• Return flights for recipient, donor and companion, with flexibility to change dates if recovery is slow
• Accommodation near the hospital for the whole stay, commonly about 4-6 weeks and longer after complications or authorization delays
• Meals, local transport and airport transfers
• Visa fees, travel insurance and any attendant or donor visa costs
• Follow-up tests and consultations at home

Kidney Transplant Quotation Comparison Table

Remote Case Review Before Travel

Send recipient diagnosis, dialysis history, blood group, CBC/chemistry, viral screening, cardiac tests and prior transplant/transfusion/pregnancy history. For the donor send relationship/documentation, blood group, creatinine/eGFR, urine tests, medical history and any CT/HLA testing already performed. The hospital should first assess medical plausibility and legal pathway before expensive travel.

Questions the Pre-Travel Opinion Should Answer

Is the recipient transplantable now? Is the proposed donor medically suitable for full evaluation? Are blood groups compatible? What HLA/crossmatch/DSA tests are needed? Is ABO-incompatible transplant or paired exchange relevant? What authorization documents are required? No legitimate centre should guarantee donor approval before full independent evaluation.

International Patient Treatment Journey

1) Remote recipient/donor screening. 2) document/legal pre-check. 3) travel and comprehensive evaluation. 4) HLA/crossmatch/immunology. 5) authorization. 6) donor nephrectomy and recipient transplant. 7) early graft monitoring. 8) stent/drug-level follow-up. 9) fit-to-fly. 10) shared long-term nephrology care. Timelines can be extended by authorization or unexpected donor findings.

How Long to Stay in India

For an uncomplicated compatible living-donor transplant, international families should commonly plan about 4-6 weeks in India including evaluation/authorization and early follow-up. ABO-incompatible or complicated cases may require longer. Do not book inflexible return flights.

Flying After Kidney Transplant for International Patients in India

Travel should wait until graft function, hydration, blood pressure, wound, infection status and immunosuppressant levels are stable. The patient must have adequate medicines and a plan for laboratory monitoring at destination. Long-haul DVT precautions should be individualized.

Travelling With Immunosuppressants

Carry medicines in hand luggage in original packaging with a prescription and generic names. Bring extra supply for delays. Tacrolimus/cyclosporine brands should not be switched casually because bioavailability can differ. Dose timing should be planned across time zones.

Airline and Travel Practicalities After Kidney Transplant

Airline rules differ, so confirm each point with your airline before you fly:

Accommodation and Companion

A caregiver is essential for the recipient, for help with medicines, appointments, drug-level tests, hydration, infection precautions and decisions over weeks. The living donor also needs their own recovery plan and separate support. Accommodation should be clean, close to the hospital and arranged for the whole stay so that fever, reduced urine or other problems can be reviewed promptly.

Medical Visa and Travel Planning

Confirm current Indian medical-visa requirements through official channels, including the attendant visa for your companion and the visa category for a living donor. Carry the hospital invitation, a medical summary, your records, relationship and legal documents and your medicines, and keep the visa duration and return travel flexible in case authorization or recovery takes longer than planned.

Continuing Care at Home

Arrange creatinine/eGFR, electrolytes, CBC, glucose, urine protein and immunosuppressant trough levels. Provide the home nephrologist with donor/recipient immunology, operative report, discharge medicines and infection prophylaxis. Rapid communication is important if creatinine rises.

Donor Follow-Up at Home

The donor should receive a discharge summary and plan for blood pressure, creatinine/eGFR, urine protein and general health monitoring. Healthy weight, exercise and avoidance of unnecessary nephrotoxic drugs support long-term kidney health. Donation follow-up should not end when the recipient leaves hospital.

Arranging Your Follow-Up Care at Home Before You Leave

Monitoring and immunosuppression continue for the life of the graft, so set up your home team before you travel and confirm it again before you fly home:

Warning Signs

Urgent assessment is required for fever, reduced urine output, sudden swelling, breathlessness, severe vomiting/diarrhea, inability to take immunosuppressants, graft-area pain, wound drainage or rapidly rising blood pressure. Donors should seek care for fever, wound problems, severe pain or urinary symptoms. Do not wait for an overseas teleconsultation when acute graft dysfunction or sepsis is possible.

Twenty Questions to Ask the Kidney Transplant Team

1. 1Am I medically suitable for transplantation now?
2. 2Is my proposed donor suitable to begin full evaluation?
3. 3What legal authorization applies to our relationship/nationality?
4. 4What blood-group compatibility do we have?
5. 5What HLA typing and crossmatch tests will be performed?
6. 6Do I have donor-specific antibodies?
7. 7Would paired kidney exchange be preferable if we are incompatible?
8. 8Is ABO-incompatible transplantation appropriate?
9. 9What is your annual living-donor transplant volume?
10. 10What are your one-year patient and graft survival outcomes?
11. 11What are your donor complication outcomes?
12. 12Will the donor nephrectomy be laparoscopic?
13. 13What induction immunosuppression will I receive?
14. 14What maintenance medicines and monthly costs should I expect?
15. 15How do you monitor CMV and BK virus?
16. 16What happens if the kidney has delayed function?
17. 17What costs are excluded for rejection, dialysis or infection?
18. 18How long must donor and recipient remain in India?
19. 19When can we safely fly home?
20. 20What exact laboratory and drug-level monitoring is required after return?

Who Is a Good Candidate for Kidney Transplant Medical Travel?

A suitable international patient is clinically stable enough to travel, has irreversible kidney failure and a legitimate transplant pathway, usually with a willing potential living donor who can undergo independent evaluation. The patient must also have reliable access to lifelong immunosuppressants, laboratory testing and nephrology care after returning home.

When Travel Should Not Delay Urgent Care

Pulmonary edema, severe hyperkalemia, sepsis, dialysis-access infection, hypertensive emergency, unstable cardiac disease or other life-threatening complications require immediate local stabilization. Transplant travel should begin only when the patient is adequately dialyzed and medically fit.

Frequently Asked Questions About Kidney Transplant for International Patients in India

Kidney Transplant Checklist for International Patients in India

Swipe to Read

Final Perspective

Kidney transplantation is a long-term medical partnership rather than a one-time operation. The recipient needs careful cardiovascular, infectious and immunologic assessment; the living donor requires independent protection and lifelong respect for donor health; and both parties must complete the applicable ethical and legal authorization process.

India has established living-donor kidney-transplant programmes, advanced HLA laboratories, ABO-incompatible and paired-exchange expertise at selected centres, and substantial private self-pay cost advantages. International patients should choose a licensed programme that is transparent about donor safety, graft outcomes, complication costs and post-return monitoring rather than focusing only on the advertised transplant package.

Important Medical Note. This guide provides general educational information and does not replace individualized assessment by a licensed kidney-transplant programme. Donor eligibility, legal authorization, compatibility, desensitization, surgery, immunosuppression, cost and travel timing must be determined from current regulations and the recipient's and donor's complete medical evaluation. Organ purchase or commercial donor arrangements are illegal and should never be pursued.